|
John E. Repine, M.D.
President and Director, Webb-Waring Institute for Cancer, Aging, and Antioxidant Research; Professor of Medicine, Associate Dean for Student Advocacy, School of Medicine, University of Colorado Denver; M.D., University of Minnesota School of Medicine; American Heart Association's Established Investigator Award; University of Colorado's President's Excellence in Teaching Award; American Society of Clinical Investigation, Association of American Physicians, Oxygen Society Councilor; Society for Critical Care Medicine, Leukocyte Biology Society , and The Shock Society Member.
Dr. John Repine is the President and Director of the Webb-Waring Institute for Cancer, Aging, and Antioxidant Research. Dr. Repine is also the James J. Waring Professor in the Department of Medicine and Pediatrics at the University of Colorado Denver.
Dr. Repine has led the Webb-Waring Institute since 1989. Under his leadership the Institute's research program has shifted its focus to a multi-disciplinary study of cancer, aging, and antioxidants. This strategy brings together M.D. and Ph.D. chemists, biochemists, cell biologists, physiologists and physicians in an interactive approach to discovering the nature of the processes that cause these disorders and how these processes can be prevented.
Dr. Repine is the author of more than 200 original peer-reviewed research articles, 50 review articles, 50 book chapters, and more than 300 abstracts, Dr. Repine is also a reviewer and on the editorial boards of several prominent professional journals. A respected authority in the study of vascular diseases including the Acute Respiratory Distress Syndrome (ARDS), ischemia-reperfusion disorders (heart attack and stroke) and cancer, he has lectured at more than 200 national and international meetings and symposia.
Dr. Repine is a member of many professional and honorary societies for medicine, chemistry and biology. He was elected to the American Society of Clinical Investigation, Association of American Physicians and is an elected counselor in the Oxygen Society. He is the recipient of an Established Investigator Award from the American Heart Association, Basil O'Conner Research Award from the March of Dimes and the Bonfils-Stanton Award for his outstanding contributions to medicine and science.
Working closely with industry, Dr. Repine serves on the scientific advisory boards of a number of biotechnology companies and is currently developing, testing and patenting promising products for the treatment and prevention of disease. He holds 7 patents. Dr. Repine has also been a leader and member of many local and national committees including the Executive Committee of the University of Colorado Global Change and Environmental Quality Program, the Medical Student Research Program, the University of Colorado Technology Transfer Program and the International Task Force regarding the role of Oxidants in Emphysema and Lung Cancer.
An Associate Dean for Student Advocacy for the University of Colorado School of Medicine, Dr. Repine is widely recognized as a distinguished teacher. He has won numerous awards including the Distinguished Faculty Scholar Award, the Dean Joseph W. St. Geme Award for Outstanding Contributions to the School of Medicine and the prestigious University of Colorado Presidential Teaching Award for 1995. Dr. Repine's students have also won many awards including advanced fellowships and are located nationwide in medical centers and industry.
Dr. Repine grew up in the Midwest. He graduated from the University of Wisconsin in 1967 and obtained his M.D. in 1971 from the University of Minnesota School of Medicine where he won the Borden Prize for outstanding research. Dr. Repine completed advanced clinical training in internal medicine and a fellowship in pulmonary medicine before becoming a faculty member. Dr. Repine is married to Karen Repine, M.D., an ophthalmologist who practices at Swedish Hospital. They have three children.
Dr. Repine's E-mail address: john.repine@uchsc.edu
|